Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
107M
-
Number of holders
-
86
-
Total 13F shares, excl. options
-
42.1M
-
Shares change
-
+5.32M
-
Total reported value, excl. options
-
$622M
-
Value change
-
+$68.8M
-
Put/Call ratio
-
0.87
-
Number of buys
-
51
-
Number of sells
-
-26
-
Price
-
$14.82
Significant Holders of ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) as of Q4 2018
103 filings reported holding RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share as of Q4 2018.
ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) has 86 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42.1M shares
of 107M outstanding shares and own 39.27% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (16M shares), TANG CAPITAL MANAGEMENT LLC (2.97M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2.06M shares), BOXER CAPITAL, LLC (1.97M shares), Cormorant Asset Management, LP (1.95M shares), BlackRock Inc. (1.94M shares), BRIDGER MANAGEMENT, LLC (1.75M shares), FMR LLC (1.47M shares), Vanguard Group Inc (1.14M shares), and CITADEL ADVISORS LLC (1.08M shares).
This table shows the top 86 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.